by Simran Chahal | Nov 25, 2015 | News
Augurex is pleased to announce that the JOINTstat™ (14-3-3η) blood test has been cleared for clinical use in Australia by the Therapeutic Goods Administration (TGA). The test is indicated for the diagnosis of rheumatoid arthritis (RA) and the assessment and monitoring...
by Simran Chahal | Jul 22, 2015 | Health, News
Expanded Use Indications JOINTstat™, a clinically game-changing blood test for Rheumatoid Arthritis (RA), now has expanded use indications in Canada and the EU. This novel test, which measures a protein called 14-3-3η, was first indicated for diagnostic use in RA....
by Simran Chahal | Jul 6, 2015 | News
PREVENTION AND TREATMENT If you have been experiencing a prolonged period of pain, tenderness and stiffness around your joints, you should get to a doctor — and make it fast. Please read the full article on the personalhealthnews.ca website here...
by Simran Chahal | Feb 3, 2015 | News
LifeLabs Medical Laboratory Services, the country’s largest provider of community laboratory services, yesterday announced the Canadian launch of JOINTstat™ (14-3-3η), a biomarker blood test that is providing transformational insights into autoimmune joint...
by Simran Chahal | Feb 2, 2015 | News
TORONTO, ONTARIO and VANCOUVER, BRITISH COLUMBIA–(Marketwired – Feb. 2, 2015) – LifeLabs Medical Laboratory Services (“LifeLabs”) announced today the launch of JOINTstat™, a diagnostic blood test for rheumatoid arthritis. The JOINTstat™...
by Simran Chahal | Nov 5, 2014 | Health, News
Vancouver, BC – November 5, 2014. Augurex Life Sciences Corp. announces a burgeoning body of data that further reveals the important role of a protein measured in blood, called 14-3-3eta, in rheumatoid arthritis (RA). Ten studies will be presented at the world’s...
